| Customization: | Available |
|---|---|
| Packing: | Customization |
| Materials: | PP/Glass |
|
Still deciding? Get samples of US$ 0.1/bottle
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Alanyl Glutamine Injection is a sterile, non-pyrogenic solution specifically designed for intravenous administration. It contains 20g of Alanyl Glutamine per 100ml, providing a stable and bioavailable source of glutamine, a conditionally essential amino acid crucial for various metabolic processes.
Active Ingredient: Alanyl Glutamine (N(2)-L-Alanyl-L-Glutamine)
Concentration: 20g/100ml
Formulation: Clear, colorless solution
Administration: Intravenous infusion
Packaging: Single-dose vial or bag, 100ml per unit
Alanyl Glutamine Injection is primarily used in clinical settings to:
Support patients with catabolic conditions (e.g., severe trauma, burns, or major surgeries).
Provide nutritional support for patients who cannot synthesize sufficient glutamine.
Enhance recovery in critically ill patients or those with compromised immune function.
Glutamine is a vital nutrient for rapidly dividing cells, such as immune cells and enterocytes.
Alanyl Glutamine is a stable dipeptide that hydrolyzes into L-alanine and L-glutamine upon administration, ensuring efficient delivery of glutamine to tissues.
Recommended Dosage: Typically 1.5-2.0 ml/kg body weight per day, adjusted based on patient needs and clinical conditions.
Administration: Must be diluted before use and administered as part of a total parenteral nutrition (TPN) solution.
Infusion Rate: Controlled infusion to avoid potential side effects.
Stability: Alanyl Glutamine is more stable in solution compared to free glutamine.
Bioavailability: Ensures rapid and efficient delivery of glutamine to tissues.
Safety: Well-tolerated with a low risk of adverse effects when used as directed.
Storage: Store at controlled room temperature (15-30°C). Protect from light and freezing.
Shelf Life: Typically 24-36 months, depending on the manufacturer.
Contraindicated in patients with severe hepatic or renal impairment.
Monitor electrolyte levels during prolonged use.
Use with caution in patients with metabolic acidosis.
){kind=link}